Bcr: A negative regulator of the Bcr-Abl oncoprotein in leukemia

Oncogene

Volumn 21, Issue 56 REV. ISS. 7, 2002, Pages 8560-8567

  Arlinghaus, Ralph B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bcr Abl oncoprotein; Chronic Myelogenous Leukemia (CML); Inhibition of Bcr Abl; Phosphoserine Bcr

Indexed keywords

BCR ABL PROTEIN; ONCOPROTEIN; PHOSPHOSERINE; PROTEIN TYROSINE KINASE; RAS PROTEIN; SERINE; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; AUTOPHOSPHORYLATION; CHRONIC MYELOID LEUKEMIA; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE INDUCTION; MOUSE; NONHUMAN; OLIGOMERIZATION; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

EID: 0037049770     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206083     Document Type: Article

References (32)

1. Abe J-I, Che W, Yoshizumi M, Huang Q, Glassman M, Ohta S, Wu Y, Arlinghaus R and Berk BC. (2001). Circulation, 104, 1399-1406.
2. Annamalai AE and Colman Jr RF. (1981). J. Biol. Chem., 256, 10276-10283.
3. Arlinghaus RB. (1998). J. Crit. Rev. Oncogen., 9, 1-18.
4. Campbell M, Li W and Arlinghaus RB. (1990). Oncogene, 5, 773-776.
5. Cleghon V and Morrison Jr DK. (1994). J. Biol. Chem., 269, 17749-17755.
6. Hawk N, Liu J, Sun T, Wang Y, Wu Y and Arlinghaus RB. (2002). Cancer Res., 62, 386-390.
7. He Y, Wetheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R and Pear WS. (2002). Blood, 99, 2957-2968.
8. Kloetzer W, Kurzrock R, Smith L, Talpaz M, Spiller M, Gutterman J and Arlinghaus RB. (1985). Virology, 140, 230-238.
9. Konopka JB, Watanabe SM and Witte ON. (1984). Cell, 37, 1035-1042.
10. Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpaz M, Trujillo JM, Blick M, Beran M and Gutterman JU. (1987). Nature, 325, 631-635.
11. Li W, Draezen O, Kloetzer WS, Gale RP and Arlinghaus RB. (1989). Oncogene, 4, 127-138.
12. Lin F, Liu J, Monaco G, Sun T, Liu J, Lin H, Stephens C, Belmont J and Arlinghaus RB. (2001). Oncogene, 20, 1873-1881.
13. Liu J, Campbell M, Guo JQ, Lu D, Xian YM and Arlinghaus RB. (1993). Oncogene, 8, 101-109.
14. Liu J, Wu Y and Arlinghaus RB. (1996a). Cancer Res., 56, 5120-5124.
15. Liu J, Wu Y, Lu D, Haataja L, Heisterkamp N, Groffen J and Arlinghaus RB. (1996b). Mol. Cell Biol., 16, 998-1005.
16. Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E and Arlinghaus RB. (1993). Blood, 82, 1257-1263.
17. Maru Y and Witte ON. (1991). Cell, 67, 459-468.
18. Mayer BJ, Jackson PK, Van Etten RA and Baltimore D. (1992). Mol. Cell Biol., 12, 609-618.
19. McWhirter JR, Galasso DL and Wang JYJ. (1993). Mol. Cell Biol., 13, 7587-7595.
20. McWhirter JR and Wang JYJ. (1997). Oncogene, 15, 1625-1634.
21. Muller AJ, Pendergast M, Havlik H, Pull L, Pawson T and Witte ON. (1992). Mol. Cell Biol., 12, 5087-5093.
22. Park I, Chung J, Walsh CT, Yun Y, Strominger JL and Shin J. (1995). Proc. Natl. Acad. Sci. USA, 92, 12338-12342.
23. Pendergast AM, Muller AJ, Havlik MH, Maru Y and Witte ON. (1991). Cell, 66, 161-171.
24. Pendergast AM, Quilliam LD, Cripe LD, Bassing CH, Dai 7, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J and Gishizky ML. (1993). Cell, 75, 175-185.
25. Pluk H, Dorey K and Superti-Furga G. (2002). Cell, 108, 247-259.
26. Pull L, Liu J, Gish G, Mbalamu G, Arlinghaus R, Pelicci PG and Pawson T. (1994). EMBO, 13, 764-773.
27. Sun T, Campbell M, Gordon W and Arlinghaus RB. (2001). Biopolymers (Peptide Science), 60, 61-75.
28. Tomich JM, Marti C and Colman RF. (1981). Biochemistry, 20, 6711-6720.
29. Wang Y, Liu J, Wu Y, Luo W, Lin S-H, Lin H, Hawk N, Sun T, Guo JQ, Estrov 7, Talpaz M, Champlin R and Arlinghaus RB. (2001). Cancer Res., 61, 138-144.
30. Wu Y, Ma G, Lu D, Lin F, Xu H-J, Liu J and Arlinghaus RB. (1999). Oncogene, 18, 4416-4424.
31. Wu Y, Liu J and Arlinghaus RB. (1998). Oncogene, 16, 141-146.
32. Zhang X, Subrahmanyan R, Wong R, Gross AW and Ren R. (2001). Mol. Cell Biol., 21, 840-853.